GlucoModicum has created manufacturing capability for increased volumes

GlucoModicum has reached a capability where devices can be ordered directly from the selected supplier as a standard order. As of today a larger batch of Flint 1 devices has arrived to GlucoModicum. On parallel, GlucoModicum has reached a capability where sensors can be produced in larger volumes. These devices and sensors are used in continuous testing and piloting on a weekly and daily basis. Building this capability enables GlucoModicum to transition to mass manufacturing capability which is planned take place during Q4/2020 – Q1/2021.